Canada - TSX:DR - CA58457V5036 - Common Stock
The current stock price of DR.CA is 14.27 CAD. In the past month the price decreased by -3.25%. In the past year, price decreased by -10.08%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CSH-UN.CA | CHARTWELL RETIREMENT RESIDEN | 220.56 | 6.03B | ||
| SIA.CA | SIENNA SENIOR LIVING INC | 50.35 | 1.89B | ||
| EXE.CA | EXTENDICARE INC | 21.44 | 1.67B |
Medical Facilities Corp. engages in the provision of surgical hospitals and an ambulatory surgery center. The company is headquartered in Toronto, Ontario. The company went IPO on 2004-03-29. The firm owns a portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interests in three specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center (ASC) located in California. The specialty surgical hospitals offer a range of non-emergency surgical, imaging, diagnostic and pain management procedures, and other ancillary services such as primary and urgent care. The ambulatory surgery center performs scheduled outpatient surgical procedures, with patient stays of less than 24 hours. Its facilities include Specialty Surgical Hospitals and Ambulatory Surgery Center, which includes Newport Center Surgical. Its specialty surgical hospitals include Arkansas Surgical Hospital, Oklahoma Spine Hospital, and Sioux Falls Specialty Hospital.
MEDICAL FACILITIES CORP
4576 Yonge Street, Suite 701
TORONTO ONTARIO M2N 6N4 CA
CEO: Robert O. Horrar
Employees: 1529
Phone: 18774027162
Medical Facilities Corp. engages in the provision of surgical hospitals and an ambulatory surgery center. The company is headquartered in Toronto, Ontario. The company went IPO on 2004-03-29. The firm owns a portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interests in three specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center (ASC) located in California. The specialty surgical hospitals offer a range of non-emergency surgical, imaging, diagnostic and pain management procedures, and other ancillary services such as primary and urgent care. The ambulatory surgery center performs scheduled outpatient surgical procedures, with patient stays of less than 24 hours. Its facilities include Specialty Surgical Hospitals and Ambulatory Surgery Center, which includes Newport Center Surgical. Its specialty surgical hospitals include Arkansas Surgical Hospital, Oklahoma Spine Hospital, and Sioux Falls Specialty Hospital.
The current stock price of DR.CA is 14.27 CAD. The price decreased by -0.56% in the last trading session.
MEDICAL FACILITIES CORP (DR.CA) has a dividend yield of 2.53%. The yearly dividend amount is currently 0.36.
DR.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
9 analysts have analysed DR.CA and the average price target is 16.58 CAD. This implies a price increase of 16.15% is expected in the next year compared to the current price of 14.27.
The Revenue of MEDICAL FACILITIES CORP (DR.CA) is expected to decline by -21.98% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
MEDICAL FACILITIES CORP (DR.CA) will report earnings on 2026-03-11.
ChartMill assigns a fundamental rating of 7 / 10 to DR.CA. DR.CA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months DR.CA reported a non-GAAP Earnings per Share(EPS) of 1.32. The EPS increased by 38.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.6% | ||
| ROA | 30.18% | ||
| ROE | 94.43% | ||
| Debt/Equity | 1.02 |
9 analysts have analysed DR.CA and the average price target is 16.58 CAD. This implies a price increase of 16.15% is expected in the next year compared to the current price of 14.27.
For the next year, analysts expect an EPS growth of 32.59% and a revenue growth -21.98% for DR.CA